Barkley paused Mounjaro because of national drug shortages, not by choice
To effectively develop a PBPK model for studying mechanism-of-action-mediated DDIs, it is essential to carefully assess the extent to which these mechanisms impact pharmacokinetics
doi: 10.2337/db21-0459 70 ChengWGordianDLudwigMQPersTHSeeleyRJMyersMGJr
The most commonly reported adverse reactions in clinical trials were gastrointestinal: nausea (up to 18 to 24% of users), diarrhea (up to 17%), vomiting, constipation, decreased appetite, dyspepsia, and abdominal pain
Drug manufacturers recommend women stop taking weight loss drugs at least two months before a planned pregnancy, as not enough research has been done to fully assess the risks of taking GLP-1 medications while pregnant, according to Dr